Cellectis
Margaux Sevin, Ph.D., serves as a Senior Scientist at Cellectis since September 2021, previously holding the position of Scientist III. Prior experience includes a role as a Postdoctoral Scientist at Gustave Roussy from April 2018 to December 2020, where responsibilities encompassed managing preclinical studies, functional exploration of therapeutic targets, and supervising team members while publishing significant research findings. Margaux's earlier experience as a PhD student and Engineer at Inserm involved designing preclinical studies, securing funding for research projects, and contributing to publications in high-impact journals. Educational credentials include a Doctorate from Université Bourgogne Europe, complemented by multiple Master's degrees in Biochemistry and Cellular and Molecular Biology, as well as specialized training in animal experimentation. Margaux's research expertise focuses on oncology and blood disorders, with a strong emphasis on preclinical development and data analysis.
This person is not in any teams
This person is not in any offices
Cellectis
1 followers
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.